Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner
Noritaka Saeki, … , Shu Takeda, Yuuki Imai
Noritaka Saeki, … , Shu Takeda, Yuuki Imai
Published April 26, 2022
Citation Information: J Clin Invest. 2022;132(11):e150533. https://doi.org/10.1172/JCI150533.
View: Text | PDF
Research Article Autoimmunity Bone biology

Epigenetic regulator UHRF1 orchestrates proinflammatory gene expression in rheumatoid arthritis in a suppressive manner

  • Text
  • PDF
Abstract

Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation with aberrant epigenetic alterations, eventually leading to joint destruction. However, the epigenetic regulatory mechanisms underlying RA pathogenesis remain largely unknown. Here, we showed that ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) is a central epigenetic regulator that orchestrates multiple pathogeneses in RA in a suppressive manner. UHRF1 expression was remarkably upregulated in synovial fibroblasts (SFs) from arthritis model mice and patients with RA. Mice with SF-specific Uhrf1 conditional knockout showed more severe arthritic phenotypes than littermate controls. Uhrf1-deficient SFs also exhibited enhanced apoptosis resistance and upregulated expression of several cytokines, including Ccl20. In patients with RA, DAS28, CRP, and Th17 accumulation and apoptosis resistance were negatively correlated with UHRF1 expression in synovium. Finally, Ryuvidine administration stabilized UHRF1 ameliorated arthritis pathogeneses in a mouse model of RA. This study demonstrated that UHRF1 expressed in RA SFs can contribute to negative feedback mechanisms that suppress multiple pathogenic events in arthritis, suggesting that targeting UHRF1 could be one of the therapeutic strategies for RA.

Authors

Noritaka Saeki, Kazuki Inoue, Maky Ideta-Otsuka, Kunihiko Watamori, Shinichi Mizuki, Katsuto Takenaka, Katsuhide Igarashi, Hiromasa Miura, Shu Takeda, Yuuki Imai

×

Figure 5

Uhrf1 suppresses expression of multiple genes involved in RA via modulation of DNA methylation.

Options: View larger image (or click on image) Download as PowerPoint
Uhrf1 suppresses expression of multiple genes involved in RA via modulat...
(A) Quantification of methylated DNA after enrichment from genome DNA using MBD beads. (B) Distribution of Uhrf1-mediated methylated DNA annotated using given intervals and scores with genome features by CEAS. (C) Venn diagram to compare Uhrf1-mediated methylated DNA loci between SFs and chondrocytes using MBD-Seq data from this study and GEO GSE99335. (D) Venn diagram for 171 genes having upregulated expression in Uhrf1ΔCol6a1 SFs and 105 genes having Uhrf1-mediated methylated DNA peaks within the transcriptional start site region (± 50 kb). (E) Representative Uhrf1-mediated methylated DNA peaks visualized by Integrative Genomics Viewer. (F) KEGG pathway analysis of 105 upregulated with peaks assigned using DAVID Bioinformatics Resources. Significantly enriched pathways illustrated by gene counts and P values. Representative mRNA expression of genes included in the (G) KEGG pathways “Rheumatoid arthritis” and “Cytokine-cytokine receptor interaction” and (H) GO biological process “Negative regulation of apoptotic process” in SFs from Uhrf1fl/fl and Uhrf1ΔCol6a1 mice (n = 3) as measured by RT-qPCR. (I) ChIP-qPCR assay of Uhrf1 for Ccl20 locus in Uhrf1ΔCol6a1 and Uhrf1fl/fl SFs. (J) Quantification of Ccl20 serum levels in Uhrf1fl/fl and Uhrf1ΔCol6a1 on day 0 (n = 10) and day 10 (n = 16) after STA induction. (K) Left, flow cytometry analysis of the population of Th17 cells (CD45+, CD4+, Ccr6+) in Uhrf1fl/fl and Uhrf1ΔCol6a1 derived from STA mice on day 4 (n = 6–8) and day 10 (n = 9–10). Right, quantification of CD45+CD4+Ccr6+ cells among CD45+ cells. Mean ± SD shown. NS, not significant versus Uhrf1fl/fl. *P < 0.05 and **P < 0.01 by unpaired t test in G–J and ANOVA followed by Tukey’s test in K. Data in A, G, and H obtained from 3 independent experiments. Data in B–F obtained from combined read data from 3 independent experiments. Data in I were technically replicated 3 times. Data in J and K obtained from 6–10 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts